• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Ginkgolic Acid (13:0)

Ginkgolic Acid (13:0)

Product ID G3352
Cas No. 20261-38-5
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $215.00 In stock
5 mg $525.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ginkgolic acids are found in Ginkgo biloba and exhibit antiviral, antibiotic, and anticancer chemotherapeutic activities. In vitro, ginkgolic acids inhibit HIV protease and suppress HIV infection. Ginkgolic acids also exhibit antibacterial activity against both gram positive and gram negative bacteria, including Staphylococcus, Escherichia, and Bacillus. Ginkgolic acids also inhibit fatty acid synthase and exhibit cytotoxicity in breast cancer, lung cancer, and leukemia cells. Additionally, ginkgolic acids induce apoptosis in cancer cells through downregulation of Bcl-2 and upregulation of Bax. Ginkgolic acids may also be neurotoxic, as they increase activity of protein phosphatase 2C (PP2C) in neurons.

Product Info

Cas No.

20261-38-5

Purity

≥98%

Formula

C20H32O3

Formula Wt.

320.47

IUPAC Name

2-hydroxy-6-tridecylbenzoic acid

Synonym

6-n-Tridecylsalicylic acid, Ginkgoneolic acid

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

G3352 MSDS PDF

Info Sheet

G3352 Info Sheet PDF

Brochures

Antivirals Booklet

References

Fu Y, Hong S, Li D, et al. Novel chemical synthesis of ginkgolic acid (13:0) and evaluation of its tyrosinase inhibitory activity. J Agric Food Chem. 2013 Jun 5;61(22):5347-52. PMID: 23701207.

Oh J, Hwang IH, Hong CE, et al. Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity. J Enzyme Inhib Med Chem. 2013 Jun;28(3):565-8. PMID: 22380770.

Lü JM, Yan S, Jamaluddin S, et al. Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug;18(8):BR293-298. PMID: 22847190.

Zhou C, Li X, Du W, et al. Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis. Chemotherapy. 2010;56(5):393-402. PMID: 20948210.

Yang X, Chen J, Qian Z, et al. Study on the antibacterial activity of ginkgolic acids. Zhong Yao Cai. 2002 Sep;25(9):651-3. PMID: 12451978.

Ahlemeyer B, Selke D, Schaper C, et al. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur J Pharmacol. 2001 Oct 26;430(1):1-7. PMID: 11698056.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A5219

    Anethole Trithione

    Oltipraz analog, salivary gland secretion enhan...

    ≥98%
  • T291321

    Thiamine Mononitrate

    Vitamin B1

    ≥98%
  • V024761

    Vatalanib

    Inhibitor of VEGFR1/2/3.

    ≥98%
  • N1983

    Neuropeptide Y (3-36), human

    Endogenous peptide neurotransmitter, involved i...

    ≥95%
  • S8005

    Substance P

    Endogenous tachykinin peptide, involved in infl...

    ≥95%
  • M3196

    MHY-1485

    mTOR activator.

    ≥98%
  • A0777

    ABT-263

    BH3 mimetic; Bcl-2 and Bcl-xl inhibitor.

    ≥99%
  • O4402

    Olaparib

    PARP1/2 inhibitor.

    ≥98%
  • G8101

    Guaifenesin

    Expectorant.

    ≥98%
  • N3301

    Niacin

    Vitamin B, required for formation of NAD and NA...

    ≥98%
  • I7759

    Isoxanthohumol

    Prenylflavinoid, derivative of xanthohumol foun...

    ≥98%
  • L337521

    Linagliptin

    Modifies microvascular function

    ≥98%
  • D3429

    Dihydrocytochalasin B

    Mycotoxin derivative; actin polymerization inhi...

    ≥98%
  • M1605

    Mebendazole

    Benzimidazole; microtubule polymerization inhib...

    ≥98%
  • T3468

    Tirapazamine

    Topoisomerase II inhibitor, RPA modulator.

    ≥98%
  • N4974

    NMS-E628

    ALK and Ros1 inhibitor, Trk antagonist.

    ≥98%
  • V3479

    Vitamin K3

    Synthetic analog of 1,4-naphthoquinone, precurs...

    ≥98%
  • R2400

    RG-108

    DNMT inhibitor.

    ≥98%
  • N859610

    NVP-HDM201

    HDM2 inhibitor

    ≥99%
  • E5456

    Enocitabine

    Cytarabine derivative, nucleoside (cytosine) an...

    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only